Weight loss outcomes associated with semaglutide treatment for patients with overweight or obesity

W Ghusn, A De la Rosa, D Sacoto… - JAMA Network …, 2022 - jamanetwork.com
Importance No retrospective cohort study has assessed the effectiveness of semaglutide at
doses used in randomized clinical trials to treat obesity (ie, 1.7 and 2.4 mg). Objective To …
被引用次数：103 相关文章

Weight Loss Outcomes Associated With Semaglutide Treatment for Patients With Overweight or Obesity.

W Ghusn, A De la Rosa, D Sacoto, L Cifuentes… - JAMA Network …, 2022 - europepmc.org
Weight Loss Outcomes Associated With Semaglutide Treatment for Patients With Overweight or
Obesity. - Abstract - Europe PMC Sign in | Create an account https://orcid.org Europe PMC …
[PDF] sochob.cl

[PDF][PDF] Weight Loss Outcomes Associated With Semaglutide Treatment for Patients With Overweight or Obesity

W Ghusn, A De la Rosa, D Sacoto, L Cifuentes… - sochob.cl
Weight Loss Outcomes Associated With Semaglutide Treatment for Patients With
Overweight or Obesity Page 1 Original Investigation | Nutrition, Obesity, and Exercise …

Weight Loss Outcomes Associated with Semaglutide Treatment for Patients with Overweight or Obesity

W Ghusn, A De La Rosa, D Sacoto… - JAMA Network …, 2022 - mayoclinic.elsevierpure.com
Importance: No retrospective cohort study has assessed the effectiveness of semaglutide at
doses used in randomized clinical trials to treat obesity (ie, 1.7 and 2.4 mg). Objective: To …
[PDF] semaglutidenj.com

[PDF][PDF] Weight Loss Outcomes Associated With Semaglutide Treatment for Patients With Overweight or Obesity

W Ghusn, A De la Rosa, D Sacoto, L Cifuentes… - semaglutidenj.com
Weight Loss Outcomes Associated With Semaglutide Treatment for Patients With
Overweight or Obesity Page 1 Original Investigation | Nutrition, Obesity, and Exercise …

Weight Loss Outcomes Associated With Semaglutide Treatment for Patients With Overweight or Obesity.

W Ghusn, A De la Rosa, D Sacoto… - JAMA Network …, 2022 - search.ebscohost.com
IMPORTANCE No retrospective cohort study has assessed the effectiveness of semaglutide
at doses used in randomized clinical trials to treat obesity (ie, 1.7 and 2.4 mg). OBJECTIVE …
[HTML] nih.gov

[HTML][HTML] Weight Loss Outcomes Associated With Semaglutide Treatment for Patients With Overweight or Obesity

W Ghusn, A De la Rosa, D Sacoto, L Cifuentes… - JAMA Network …, 2022 - ncbi.nlm.nih.gov
Weight Loss Outcomes Associated With Semaglutide Treatment for Patients With
Overweight or Obesity - PMC Back to Top Skip to main content NIH NLM Logo Access keys …
[PDF] researchgate.net

[PDF][PDF] Weight Loss Outcomes Associated With Semaglutide Treatment for Patients With Overweight or Obesity

W Ghusn, A De la Rosa, D Sacoto, L Cifuentes… - researchgate.net
Weight Loss Outcomes Associated With Semaglutide Treatment for Patients With
Overweight or Obesity Page 1 Original Investigation | Nutrition, Obesity, and Exercise …

Weight Loss Outcomes Associated With Semaglutide Treatment for Patients With Overweight or Obesity

W Ghusn, A De la Rosa, D Sacoto, L Cifuentes… - 2022 - pubmed.ncbi.nlm.nih.gov
Importance No retrospective cohort study has assessed the effectiveness of semaglutide at
doses used in randomized clinical trials to treat obesity (ie, 1.7 and 2.4 mg). Objective To …
[PDF] semaglutidenj.com

[PDF][PDF] Weight Loss Outcomes Associated With Semaglutide Treatment for Patients With Overweight or Obesity

W Ghusn, A De la Rosa, D Sacoto, L Cifuentes… - semaglutidenj.com
Weight Loss Outcomes Associated With Semaglutide Treatment for Patients With
Overweight or Obesity Page 1 Original Investigation | Nutrition, Obesity, and Exercise …